Tantalizing results from small trials and anecdotes raised hopes that drugs like Ozempic could help. Despite setbacks, ...

Donald Trump appeared drowsy during a Cabinet meeting after a late-night Truth Social spree, prompting online rumors that he ...

GLP-1 drugs, which include Ozempic and Wegovy, have become one of the most closely watched experimental approaches for ...

Paul Edison, MD, PhD, of Imperial College London, who wasn't involved with the studies, called the findings "an undeniable ...

A weight loss drug similar to Ozempic appeared to slow cognitive decline in patients with mild Alzheimer’s disease, new research presented Tuesday at the Alzheimer’s Association International ...

Novo Nordisk’s stock tumbles after its oral GLP-1 drug didn’t show a statistically significant benefit over a placebo against Alzheimer’s.

Explore how smart pillboxes and dispensers help people with early-stage Alzheimer's manage medications effectively, ensuring ...

It is widely known that Alzheimer's disease is mainly associated with the overproduction of β-amyloid peptides and damage ...

Administering an amino acid used to treat high blood pressure also appears to reverse signs of dementia in mice.

Merck’s investigational antibody MK-2214 has received fast-track designation from the FDA for the treatment of Alzheimer’s disease. MK-2214 targets phosphorylated serine 413 tau (pS413), a marker of ...

Two large-scale phase 3 trials found that semaglutide did not significantly slow cognitive decline in early-stage Alzheimer’s disease despite improving bio ...

A new study reveals that obesity accelerated Alzheimer's blood biomarkers by 95% over five years, highlighting a strong ...